MAN mandrake resources limited

0.00%

1.8¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-12

First 12 Last

Share
Profile

Follow
malay

11,050 Posts.

1776

17/10/22

11:35

Post #: 64232222
Share

Originally posted by malay: ↑

I am still here because of the risk reward ratio, MAN'S $17.2 million in cash plus the enticed Delfin project. Now that Delfin has fallen over, management has to find something else quick to fill this void or else the attractive factor has diminished.
Routine quarterly report is not enough, management needs regular updates and informed expectations on project and schedules for example ; when is results due back on drilling, rock and soil sampling As usual we need to know whether we are drilling Newleyline or North, South Tolerno. We need to know the timetable if any.
As an exploration company MAN will be continuously looking for new projects. The company has not informed us of the prospects if any currently on hand to be excited about, or just like a worker, waking up each morning going to work.
Management of this company has shown no enthusiasm in their approach, no expectations and if any announcements, mainly on statutory requirements and nothing else.
Shareholders enthusiasm is correlated with management and so is the share price. Currently we haven't got anything to be over excited about. Even the Berinka project is not enough to excite us currently.
The initial appointment of the new NED was welcomed together with his initial purchase of the Company's shares. Will JA join the party or is he just going to be an observer only?
SB1's at least shown enthusiasm if not the over the top defence of management. At least he is consistent in his support of the company. I don't know it would be any good if management failed to reciprocate by giving something for shareholders to be excited about.

Expand

Currently exploration for gold is not going to stimulate any excitement even on good grades. Rare earth or lithium type commodities are well sought after. MAN should be heading that direction.

MAN Price at posting: 3.6¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

First 12 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.8¢		Change 0.000(0.00%)		Mkt cap ! $11.29M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.7¢	$19.77K	1.099M

Buyers (Bids)

No.	Vol.	Price($)
4	2303937	1.7¢

Sellers (Offers)

Price($)	Vol.	No.
1.8¢	428439	1

View Market Depth

No.	Vol.	Price($)
4	2303937	0.017
5	1076268	0.016
1	33340	0.015
3	1070000	0.014
1	80000	0.012

Price($)	Vol.	No.
0.018	428439	1
0.019	153433	5
0.020	607920	4
0.021	801168	3
0.022	1015601	2

Last trade - 15.26pm 27/06/2025 (20 minute delay)

MAN (ASX) Chart

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-12

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Boss extends June win streak with boosted Alta Mesa extraction rates

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-12

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Boss extends June win streak with boosted Alta Mesa extraction rates

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News